COST EFFECTIVENESS ANALYSIS OF THE USE OF DACLATASVIR plus ASUNAPREVIR IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C IN PERU

被引：0
|
作者：
Sanabria, C. [1 ]
Roman, R. [2 ]
Montano, D. [3 ]
Mercado, D. [3 ]
Valenzuela, G. [3 ]
Caporale, J. E. [4 ]
机构：
[1] Univ Nacl Mayor San Marcos, Lima, Peru
[2] EsSalud, Lima, Peru
[3] BMS, San Isidro, Peru
[4] BMS, Vicente Lopez, Argentina
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2910
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN25
引用
收藏
页码：A930 / A930
页数：1
相关论文
共 50 条
  • [31] Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir plus Asunaprevir Treatment
    Inoue, Jun
    Kanno, Atsushi
    Wakui, Yuta
    Miura, Masahito
    Kobayashi, Tomoo
    Morosawa, Tatsuki
    Kogure, Takayuki
    Kakazu, Eiji
    Ninomiya, Masashi
    Fujisaka, Yasuyuki
    Umetsu, Teruyuki
    Takai, Satoshi
    Nakamura, Takuya
    Shimosegawa, Tooru
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 241 (01): : 21 - 28
  • [32] Integrated pharmacokinetic/viral dynamic model for daclatasvir/asunaprevir in treatment of patients with genotype 1 chronic hepatitis C
    He-chuan Wang
    Yu-peng Ren
    Yue Qiu
    Jenny Zheng
    Gai-ling Li
    Chuan-pu Hu
    Tian-yan Zhou
    Wei Lu
    Liang Li
    Acta Pharmacologica Sinica, 2018, 39 : 140 - 153
  • [33] Retreatment of Chronic Hepatitis C Failed to Daclatasvir Plus Asunaprevir by Other Direct-acting Antivirals
    Lee, Dong Hoon
    Ryu, Soo Hyung
    Myung, Hee Jun
    Shin, Yun Jae
    Lee, Si Hyeong
    Park, Tae Young
    Moon, Jeong Seop
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2021, 77 (02): : 88 - 91
  • [34] Severe Hepatotoxicity Associated With Asunaprevir and Daclatasvir in Chronic Hepatitis C REPLY
    Fujii, Yohei
    Uchida, Yoshihito
    Mochida, Satoshi
    HEPATOLOGY, 2016, 63 (06) : 2064 - 2065
  • [35] Daclatasvir combined with asunaprevir is a cost-effective and cost-saving treatment for hepatitis C infection in China
    Chen, Wen
    Ward, Thomas
    Tan, Mai Ping
    Yan, Jing
    Wang, Peter Feng
    Wygant, Gaild D.
    Gordon, Jason
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (08) : 785 - 795
  • [36] Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease
    Kondo, Chisa
    Atsukawa, Masanori
    Tsubota, Akihito
    Shimada, Noritomo
    Abe, Hiroshi
    Asano, Toru
    Yoshizawa, Kai
    Okubo, Tomomi
    Chuganji, Yoshimichi
    Aizawa, Yoshio
    Iio, Etsuko
    Tanaka, Yasuhito
    Iwakiri, Katsuhiko
    HEPATOLOGY RESEARCH, 2017, 47 (11) : 1165 - 1173
  • [37] Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir
    Huang, Chung-Feng
    Yeh, Ming-Lun
    Huang, Ching-, I
    Liang, Po-Cheng
    Lin, Yi-Hun
    Hsieh, Ming-Yen
    Chen, Kuan-Yu
    Ko, Yu-Min
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Huang, Jee-Fu
    Dai, Chia-Yen
    Chuang, Wan-Long
    Yu, Ming-Lung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (01) : 151 - 156
  • [38] Real-world long-term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection
    Fujii, Hideki
    Kimura, Hiroyuki
    Hasebe, Chitomi
    Akahane, Takehiro
    Satou, Takashi
    Kusakabe, Atsunori
    Kojima, Yuji
    Kondo, Masahiko
    Marusawa, Hiroyuki
    Kobashi, Haruhiko
    Tsuji, Keiji
    Ogawa, Chikara
    Uchida, Yasushi
    Joko, Kouji
    Mitsuda, Akeri
    Kurosaki, Masayuki
    Izumi, Namiki
    JGH OPEN, 2022, 6 (05): : 344 - 352
  • [39] ASSESSING THE ECONOMIC IMPACT OF THE INTRODUCTION OF DACLATASVIR IN COMBINATION WITH ASUNAPREVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C IN CHINA
    Ward, T.
    Gordon, J.
    Wygant, G.
    Yan, J.
    Wang, F.
    McEwan, P.
    VALUE IN HEALTH, 2017, 20 (09) : A782 - A782
  • [40] Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy
    Saito, Yuhei
    Imamura, Michio
    Uchida, Takuro
    Osawa, Mitsutaka
    Teraoka, Yuji
    Fujino, Hatsue
    Nakahara, Takashi
    Ono, Atsushi
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Miki, Daiki
    Tsuge, Masataka
    Serikawa, Masahiro
    Aikata, Hiroshi
    Abe-Chayama, Hiromi
    Hayes, C. Nelson
    Chayama, Kazuaki
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (02) : 210 - 218
12345